Micromarkers 2.0: an update on the role of microRNAs in cancer diagnosis and prognosis

被引：24
作者：
Ferracin, Manuela
Negrini, Massimo [1 ]
机构：
[1] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy
来源：
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS | 2015年 / 15卷 / 10期
关键词：
cancer; circulating miRNAs; diagnosis; microRNA; miRNA genetics; prognosis; TCGA portal; CELL-FREE MICRORNAS; GENETIC-VARIANTS; ABSOLUTE QUANTIFICATION; CIRCULATING MICRORNAS; MIRNAS; SERUM; SIGNATURE; PLASMA; BLOOD; IDENTIFICATION;
D O I：
10.1586/14737159.2015.1081058
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
The identification of reliable diagnostic or prognostic biomarkers is one of the most pressing goals in oncological research. MicroRNAs have proven to be very promising cancer biomarkers because they are resistant to degradation in many tissue types (including FFPE specimens and body fluids), easily measured and, most importantly, their amount correlates with the presence of the tumor or with clinically relevant cancer features. In addition, our knowledge of microRNA genetic alterations in familial and sporadic cancer has recently improved. This review presents an update on cancer diagnostic and prognostic microRNAs, discusses novel tools for prognostic microRNAs identification and evaluates the possible translation of these discoveries to the clinic.
引用
收藏
页码：1369 / 1381
页数：13
相关论文
共 57 条
  • [1] [Anonymous], 2001, SCIENCE, DOI DOI 10.1126/science.1065062
  • [2] Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
    Arroyo, Jason D.
    Chevillet, John R.
    Kroh, Evan M.
    Ruf, Ingrid K.
    Pritchard, Colin C.
    Gibson, Donald F.
    Mitchell, Patrick S.
    Bennett, Christopher F.
    Pogosova-Agadjanyan, Era L.
    Stirewalt, Derek L.
    Tait, Jonathan F.
    Tewari, Muneesh
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (12) : 5003 - 5008
  • [3] Good guy or bad guy: the opposing roles of microRNA 125b in cancer
    Banzhaf-Strathmann, Julia
    Edbauer, Dieter
    [J]. CELL COMMUNICATION AND SIGNALING, 2014, 12
  • [4] Integrated genomic analyses of ovarian carcinoma
    Bell, D.
    Berchuck, A.
    Birrer, M.
    Chien, J.
    Cramer, D. W.
    Dao, F.
    Dhir, R.
    DiSaia, P.
    Gabra, H.
    Glenn, P.
    Godwin, A. K.
    Gross, J.
    Hartmann, L.
    Huang, M.
    Huntsman, D. G.
    Iacocca, M.
    Imielinski, M.
    Kalloger, S.
    Karlan, B. Y.
    Levine, D. A.
    Mills, G. B.
    Morrison, C.
    Mutch, D.
    Olvera, N.
    Orsulic, S.
    Park, K.
    Petrelli, N.
    Rabeno, B.
    Rader, J. S.
    Sikic, B. I.
    Smith-McCune, K.
    Sood, A. K.
    Bowtell, D.
    Penny, R.
    Testa, J. R.
    Chang, K.
    Dinh, H. H.
    Drummond, J. A.
    Fowler, G.
    Gunaratne, P.
    Hawes, A. C.
    Kovar, C. L.
    Lewis, L. R.
    Morgan, M. B.
    Newsham, I. F.
    Santibanez, J.
    Reid, J. G.
    Trevino, L. R.
    Wu, Y. -Q.
    Wang, M.
    [J]. NATURE, 2011, 474 (7353) : 609 - 615
  • [5] microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers
    Brunet Vega, Anna
    Pericay, Carles
    Moya, Irene
    Ferrer, Anna
    Dotor, Emma
    Pisa, Aleydis
    Casalots, Alex
    Serra-Aracil, Xavier
    Oliva, Joan-Carles
    Ruiz, Anna
    Saigi, Eugeni
    [J]. ONCOLOGY REPORTS, 2013, 30 (01) : 320 - 326
  • [6] The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
    Cerami, Ethan
    Gao, Jianjiong
    Dogrusoz, Ugur
    Gross, Benjamin E.
    Sumer, Selcuk Onur
    Aksoy, Buelent Arman
    Jacobsen, Anders
    Byrne, Caitlin J.
    Heuer, Michael L.
    Larsson, Erik
    Antipin, Yevgeniy
    Reva, Boris
    Goldberg, Arthur P.
    Sander, Chris
    Schultz, Nikolaus
    [J]. CANCER DISCOVERY, 2012, 2 (05) : 401 - 404
  • [7] Cheng HR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064795, 10.1371/journal.pone.0053008]
  • [8] Comprehensive genomic characterization defines human glioblastoma genes and core pathways
    Chin, L.
    Meyerson, M.
    Aldape, K.
    Bigner, D.
    Mikkelsen, T.
    VandenBerg, S.
    Kahn, A.
    Penny, R.
    Ferguson, M. L.
    Gerhard, D. S.
    Getz, G.
    Brennan, C.
    Taylor, B. S.
    Winckler, W.
    Park, P.
    Ladanyi, M.
    Hoadley, K. A.
    Verhaak, R. G. W.
    Hayes, D. N.
    Spellman, Paul T.
    Absher, D.
    Weir, B. A.
    Ding, L.
    Wheeler, D.
    Lawrence, M. S.
    Cibulskis, K.
    Mardis, E.
    Zhang, Jinghui
    Wilson, R. K.
    Donehower, L.
    Wheeler, D. A.
    Purdom, E.
    Wallis, J.
    Laird, P. W.
    Herman, J. G.
    Schuebel, K. E.
    Weisenberger, D. J.
    Baylin, S. B.
    Schultz, N.
    Yao, Jun
    Wiedemeyer, R.
    Weinstein, J.
    Sander, C.
    Gibbs, R. A.
    Gray, J.
    Kucherlapati, R.
    Lander, E. S.
    Myers, R. M.
    Perou, C. M.
    McLendon, Roger
    [J]. NATURE, 2008, 455 (7216) : 1061 - 1068
  • [9] Mature MicroRNA Sequence Polymorphism in MIR196A2 Is Associated with Risk and Prognosis of Head and Neck Cancer
    Christensen, Brock C.
    Avissar-Whiting, Michele
    Ouellet, Lauren G.
    Butler, Rondi A.
    Nelson, Heather H.
    McClean, Michael D.
    Marsit, Carmen J.
    Kelsey, Karl T.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (14) : 3713 - 3720
  • [10] Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer
    Christinat, Yann
    Krek, Wilhelm
    [J]. ONCOTARGET, 2015, 6 (12) : 10521 - 10531
123456